David M. Schwope

发表

Cannabinoid stability in authentic oral fluid after controlled cannabis smoking.

M. Huestis, D. Gorelick, Allan J. Barnes, 2012, Clinical chemistry.

Cannabinoid disposition in oral fluid after controlled smoked cannabis.

M. Huestis, D. Gorelick, Allan J Barnes, 2012, Clinical chemistry.

Validation of an enzyme immunoassay for detection and semiquantification of cannabinoids in oral fluid.

M. Huestis, D. Schwope, G. Milman, 2010, Clinical chemistry.

In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.

Nathalie A. Desrosiers, M. Huestis, D. Gorelick, 2013, Clinical chemistry.

Tolerance to effects of high-dose oral δ9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers.

D. Kelly, M. Huestis, D. Gorelick, 2013, Journal of analytical toxicology.

Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC.

D. Kelly, M. Huestis, D. Gorelick, 2012, Drug and alcohol dependence.

Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.

D. Kelly, M. Huestis, D. Gorelick, 2009, Clinical chemistry.

On-site test for cannabinoids in oral fluid.

Nathalie A. Desrosiers, M. Huestis, D. Gorelick, 2012, Clinical chemistry.

Determining zolpidem compliance: urinary metabolite detection and prevalence in chronic pain patients.

R. Heltsley, E. Cone, Y. Caplan, 2014, Journal of analytical toxicology.

Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.

D. Kelly, M. Huestis, D. Gorelick, 2011, Clinical chemistry.

Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers.

D. Kelly, M. Huestis, D. Gorelick, 2013, The American journal on addictions.

Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.

M. Huestis, D. Gorelick, G. Milman, 2012, Clinica chimica acta; international journal of clinical chemistry.

Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration.

D. Kelly, M. Huestis, D. Gorelick, 2010, Clinical chemistry.

Detection and quantification of low levels of benzoylecgonine in equine urine.

R. Gaensslen, A. Negrusz, M. Benoît, 2008, Forensic science international.

Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography–tandem mass spectrometry

M. Huestis, K. Scheidweiler, D. Schwope, 2011, Analytical and bioanalytical chemistry.

Widespread Distribution of Xylazine Detected Throughout the United States in Healthcare Patient Samples

R. Heltsley, J. Schrecker, Kathy Le, 2023, Journal of addiction medicine.

Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis.

Marilyn A Huestis, W. M. Bosker, J. Ramaekers, 2012, Journal of analytical toxicology.

Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.

M. Huestis, D. Gorelick, D. Schwope, 2011, Clinical chemistry.

Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration

M. Huestis, D. Gorelick, Allan J. Barnes, 2011, Analytical and bioanalytical chemistry.

Characterization of drug-drug interactions in patients whose substance intake was objectively identified by detection in urine

J. Schrecker, B. Puet, Cheryl Hild, 2018, Expert opinion on drug metabolism & toxicology.

Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH).

M. Huestis, M. Holland, R. Stoppacher, 2011, Forensic science international.

Presence of Parent Cocaine in the Absence of Benzoylecgonine in Urine.

R. Heltsley, B. Puet, David M. Schwope, 2018, Journal of analytical toxicology.

Antagonist-Elicited Cannabis Withdrawal in Humans

D. Kelly, M. Huestis, D. Gorelick, 2011, Journal of clinical psychopharmacology.

Cannabinoid stability in authentic oral fluid after controlled cannabis smoking.

M. Huestis, D. Gorelick, Allan J. Barnes, 2012, Clinical chemistry.

Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.

M. Huestis, D. Gorelick, David M. Schwope, 2011, Clinical chemistry.